microdosing glp-1 for arthritis is popular, but there's little evidence it works GLP-1 Medications and Rheumatoid Arthritis:
Description
2024 doi: 10.1007/s11606-024-09084-z

While they may not be as effective as GLP-1s, they can still support weight management efforts

Methods We searched PubMed, Embase, Cochrane and ClinicalTrials.gov up until 27 October 2021 for randomised controlled trials with a duration of at least 12 weeks that compared once-weekly tirzepatide 5, 10 or 15 mg with placebo or other glucose-lowering drugs in adults with type 2 diabetes irrespective of their background glucose-lowering treatment

& Dubourg, J

Whereas, the obesity segment will expand at a significant CAGR, with the raised adoption of GLP-1 receptor agonist along with its possession of dual action are fueling the overall market growth

No cost with most insurance
